Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
184,457
clinical trials

Relapsed or Refractory Mantle Cell Lymphoma Clinical Trial
An Open Label Treatment Use Protocol for Ibrutinib in Subjects With Relapsed or Refractory Mantle Cell Lymphoma
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Relapsed or Refractory Mantle Cell Lymphoma Clinical Trial
An Open Label Treatment Use Protocol for Ibrutinib in Subjects With Relapsed or Refractory Mantle Cell Lymphoma
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
La Jolla, CA
Click here to add this to my saved trials
Relapsed or Refractory Mantle Cell Lymphoma Clinical Trial
An Open Label Treatment Use Protocol for Ibrutinib in Subjects With Relapsed or Refractory Mantle Cell Lymphoma
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Lexington, KY
Click here to add this to my saved trials
Relapsed or Refractory Mantle Cell Lymphoma Clinical Trial
An Open Label Treatment Use Protocol for Ibrutinib in Subjects With Relapsed or Refractory Mantle Cell Lymphoma
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Louisville, KY
Click here to add this to my saved trials
Relapsed or Refractory Mantle Cell Lymphoma Clinical Trial
An Open Label Treatment Use Protocol for Ibrutinib in Subjects With Relapsed or Refractory Mantle Cell Lymphoma
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
Relapsed or Refractory Mantle Cell Lymphoma Clinical Trial
An Open Label Treatment Use Protocol for Ibrutinib in Subjects With Relapsed or Refractory Mantle Cell Lymphoma
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Palm Beach Gardens, FL
Click here to add this to my saved trials
Relapsed or Refractory Mantle Cell Lymphoma Clinical Trial
An Open Label Treatment Use Protocol for Ibrutinib in Subjects With Relapsed or Refractory Mantle Cell Lymphoma
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Relapsed or Refractory Mantle Cell Lymphoma Clinical Trial
An Open Label Treatment Use Protocol for Ibrutinib in Subjects With Relapsed or Refractory Mantle Cell Lymphoma
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Rochester, MN
Click here to add this to my saved trials
Relapsed or Refractory Mantle Cell Lymphoma Clinical Trial
An Open Label Treatment Use Protocol for Ibrutinib in Subjects With Relapsed or Refractory Mantle Cell Lymphoma
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Sioux City, IA
Click here to add this to my saved trials
Relapsed or Refractory Mantle Cell Lymphoma Clinical Trial
An Open Label Treatment Use Protocol for Ibrutinib in Subjects With Relapsed or Refractory Mantle Cell Lymphoma
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Stamford, CT
Click here to add this to my saved trials
Relapsed or Refractory Mantle Cell Lymphoma Clinical Trial
An Open Label Treatment Use Protocol for Ibrutinib in Subjects With Relapsed or Refractory Mantle Cell Lymphoma
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Stanford, CA
Click here to add this to my saved trials
Relapsed or Refractory Mantle Cell Lymphoma Clinical Trial
An Open Label Treatment Use Protocol for Ibrutinib in Subjects With Relapsed or Refractory Mantle Cell Lymphoma
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Syracuse, NY
Click here to add this to my saved trials
Relapsed or Refractory Mantle Cell Lymphoma Clinical Trial
An Open Label Treatment Use Protocol for Ibrutinib in Subjects With Relapsed or Refractory Mantle Cell Lymphoma
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Washington DC,
Click here to add this to my saved trials
Relapsed or Refractory Mantle Cell Lymphoma Clinical Trial
An Open Label Treatment Use Protocol for Ibrutinib in Subjects With Relapsed or Refractory Mantle Cell Lymphoma
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Watertown, SD
Click here to add this to my saved trials
Relapsed or Refractory Mantle Cell Lymphoma Clinical Trial
An Open Label Treatment Use Protocol for Ibrutinib in Subjects With Relapsed or Refractory Mantle Cell Lymphoma
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Worcester, MA
Click here to add this to my saved trials
Ulcerative Colitis (UC) Clinical Trial
A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)
Status: Enrolling, Phase
Updated: 12/31/1969
Investigative Clinical Research /ID# 102056
mi
from
Annapolis, MD
Click here to add this to my saved trials
Ulcerative Colitis (UC) Clinical Trial
A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)
Status: Enrolling, Phase
Updated: 12/31/1969
Rush University Medical Center /ID# 132979
mi
from
Chicago, IL
Click here to add this to my saved trials
Ulcerative Colitis (UC) Clinical Trial
A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)
Status: Enrolling, Phase
Updated: 12/31/1969
Iowa Digestive Disease Center /ID# 107159
mi
from
Clive, IA
Click here to add this to my saved trials
Ulcerative Colitis (UC) Clinical Trial
A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)
Status: Enrolling, Phase
Updated: 12/31/1969
Carolina Research, Greenville, NC /ID# 134133
mi
from
Greenville, NC
Click here to add this to my saved trials
Ulcerative Colitis (UC) Clinical Trial
A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)
Status: Enrolling, Phase
Updated: 12/31/1969
Kelsey-Seybold Clinic /ID# 125942
mi
from
Houston, TX
Click here to add this to my saved trials
Ulcerative Colitis (UC) Clinical Trial
A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)
Status: Enrolling, Phase
Updated: 12/31/1969
Grand Teton Research Group /ID# 108197
mi
from
Idaho Falls, ID
Click here to add this to my saved trials
Ulcerative Colitis (UC) Clinical Trial
A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)
Status: Enrolling, Phase
Updated: 12/31/1969
Yale University Digestive Diseases /ID# 141987
mi
from
New Haven, CT
Click here to add this to my saved trials
Ulcerative Colitis (UC) Clinical Trial
A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)
Status: Enrolling, Phase
Updated: 12/31/1969
Premier Medical Group /ID# 140388
mi
from
New Windsor, NY
Click here to add this to my saved trials
Ulcerative Colitis (UC) Clinical Trial
A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)
Status: Enrolling, Phase
Updated: 12/31/1969
Digestive Health Center /ID# 113897
mi
from
Pasadena, TX
Click here to add this to my saved trials
Ulcerative Colitis (UC) Clinical Trial
A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)
Status: Enrolling, Phase
Updated: 12/31/1969
Temple University Hospital /ID# 108203
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Ulcerative Colitis (UC) Clinical Trial
A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)
Status: Enrolling, Phase
Updated: 12/31/1969
Washington University School of Medicine /ID# 107156
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Ulcerative Colitis (UC) Clinical Trial
A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)
Status: Enrolling, Phase
Updated: 12/31/1969
University of Washington /ID# 122076
mi
from
Seattle, WA
Click here to add this to my saved trials
Ulcerative Colitis (UC) Clinical Trial
A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)
Status: Enrolling, Phase
Updated: 12/31/1969
Granger Medical Clinic /ID# 122896
mi
from
West Valley City, UT
Click here to add this to my saved trials
Ulcerative Colitis (UC) Clinical Trial
A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)
Status: Enrolling, Phase
Updated: 12/31/1969
Trial Management Associates; LLC /ID# 138459
mi
from
Wilmington, NC
Click here to add this to my saved trials
Ulcerative Colitis (UC) Clinical Trial
A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)
Status: Enrolling, Phase
Updated: 12/31/1969
St. Joseph Heritage Group /ID# 133721
mi
from
Yorba Linda, CA
Click here to add this to my saved trials
Urinary Incontinence Clinical Trial
A Long-Term Extension Study of OnabotulinumtoxinA for Urinary Incontinence Due to Neurogenic Detrusor Overactivity
Status: Enrolling, Phase III
Updated: 12/31/1969
Medical University Hospital
mi
from
Innsbruck,
Click here to add this to my saved trials
Pharmacology / Toxicology Clinical Trial
BMN 110 US Expanded Access Program
Status: Enrolling
Updated: 10/4/2013
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
Pharmacology / Toxicology Clinical Trial
BMN 110 US Expanded Access Program
Status: Enrolling
Updated: 10/4/2013
Clinical Research Facility
mi
from
Louisville, KY
Click here to add this to my saved trials
Pharmacology / Toxicology Clinical Trial
BMN 110 US Expanded Access Program
Status: Enrolling
Updated: 10/4/2013
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
Pharmacology / Toxicology Clinical Trial
BMN 110 US Expanded Access Program
Status: Enrolling
Updated: 10/4/2013
Clinical Research Facility
mi
from
Tacoma, WA
Click here to add this to my saved trials
Pharmacology / Toxicology Clinical Trial
BMN 110 US Expanded Access Program
Status: Enrolling
Updated: 10/4/2013
Clinical Research Facility
mi
from
Washington DC,
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
Anchorage Associates in Radiation Medicine
mi
from
Anchorage, AK
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
PCR Oncology
mi
from
Arroyo Grande, CA
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
Nebraska Medicine-Bellevue
mi
from
Bellevue, NE
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
West Virginia University Charleston Division
mi
from
Charleston, WV
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
Haywood Infusion Center
mi
from
Clyde, NC
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
Great Lakes Cancer Management Specialists-Doctors Park
mi
from
East China Township, MI
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
Sanford Broadway Medical Center
mi
from
Fargo, ND
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
Sanford South University Medical Center
mi
from
Fargo, ND
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
Essentia Health - Fosston
mi
from
Fosston, MN
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
Vidant Oncology-Kinston
mi
from
Kinston, NC
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
Ann M Wierman MD LTD
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
Nevada Cancer Specialists-Tenaya
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
PeaceHealth Saint John Medical Center
mi
from
Longview, WA
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Mary's Oncology/Hematology Associates of Marlette
mi
from
Marlette, MI
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
WVUH-Berkely Medical Center
mi
from
Martinsburg, WV
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Alphonsus Medical Center-Nampa
mi
from
Nampa, ID
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
Community Cancer Center Foundation
mi
from
Normal, IL
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
Hope Cancer Center
mi
from
Pontiac, MI
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
21st Century Oncology-Pontiac
mi
from
Pontiac, MI
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
Kaiser Permanente Downtown Commons
mi
from
Sacramento, CA
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
Lakeland Medical Center Saint Joseph
mi
from
Saint Joseph, MI
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
Smilow Cancer Hospital-Torrington Care Center
mi
from
Torrington, CT
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
ProHealth Waukesha Memorial Hospital
mi
from
Waukesha, WI
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
WellSpan Health-York Hospital
mi
from
York, PA
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
Huron Gastroenterology PC
mi
from
Ypsilanti, MI
Click here to add this to my saved trials
Newly Diagnosed Ewing Sarcoma Clinical Trial
Irinotecan and Temozolomide in Combination With Existing High Dose Alkylator Based Chemotherapy for Treatment of Patients With Newly Diagnosed Ewing Sarcoma
Status: Enrolling, Phase II
Updated: 12/31/1969
Memorial Sloan Kettering Monmouth
mi
from
Middletown, NJ
Click here to add this to my saved trials
Acute Kidney Injury Clinical Trial
Identification and Validation of Biomarkers of Acute Kidney Injury Recovery
Status: Enrolling
Updated: 4/17/2014
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
Acute Kidney Injury Clinical Trial
Identification and Validation of Biomarkers of Acute Kidney Injury Recovery
Status: Enrolling
Updated: 4/17/2014
Clinical Research Facility
mi
from
Gainesville, FL
Click here to add this to my saved trials
Oncology Clinical Trial
Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery
Status: Enrolling, Phase III
Updated: 5/4/2017
Memorial Sloan Kettering Westchester
mi
from
Harrison, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery
Status: Enrolling, Phase III
Updated: 5/4/2017
Memorial Sloan Kettering Sleepy Hollow
mi
from
Sleepy Hollow, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery
Status: Enrolling, Phase III
Updated: 5/4/2017
Montefiore Medical Center - Moses Campus
mi
from
The Bronx, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery
Status: Enrolling, Phase III
Updated: 5/4/2017
ProHealth Waukesha Memorial Hospital
mi
from
Waukesha, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery
Status: Enrolling, Phase III
Updated: 5/4/2017
Henry Ford West Bloomfield Hospital
mi
from
West Bloomfield Township, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery
Status: Enrolling, Phase III
Updated: 5/4/2017
WellSpan Health-York Hospital
mi
from
York, PA
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Renal Artery Denervation In Addition to Catheter Ablation To Eliminate Atrial Fibrillation
Status: Enrolling, Phase III
Updated: 9/24/2015
State Research Institute of Circulation Pathology
mi
from
Novosibirsk,
Click here to add this to my saved trials
Medulloblastoma Clinical Trial
A Clinical and Molecular Risk-Directed Therapy for Newly Diagnosed Medulloblastoma
Status: Enrolling, Phase II
Updated: 12/31/1969
Sydney Children's Hospital
mi
from
Randwick,
Click here to add this to my saved trials
Oncology Clinical Trial
AZD8186 First Time In Patient Ascending Dose Study
Status: Enrolling, Phase I
Updated: 12/31/1969
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Oncology Clinical Trial
AZD8186 First Time In Patient Ascending Dose Study
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Toronto,
Click here to add this to my saved trials
HEAD AND NECK CANCER Clinical Trial
Randomized Trial of Intensity-Modulated Proton Beam Therapy (IMPT) Versus Intensity-Modulated Photon Therapy (IMRT) for the Treatment of Oropharyngeal Cancer of the Head and Neck
Status: Enrolling, Phase II, III
Updated: 12/31/1969
University of Pennsylvania Health System
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Anchorage Associates in Radiation Medicine
mi
from
Anchorage, AK
Click here to add this to my saved trials
Oncology Clinical Trial
Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
PCR Oncology
mi
from
Arroyo Grande, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Siteman Cancer Center at West County Hospital
mi
from
Creve Coeur, MO
Click here to add this to my saved trials
Oncology Clinical Trial
Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Essentia Health - Fosston
mi
from
Fosston, MN
Click here to add this to my saved trials
Oncology Clinical Trial
Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Ann M Wierman MD LTD
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Oncology Clinical Trial
Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
PeaceHealth Saint John Medical Center
mi
from
Longview, WA
Click here to add this to my saved trials
Oncology Clinical Trial
Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
WVUH-Berkely Medical Center
mi
from
Martinsburg, WV
Click here to add this to my saved trials
Oncology Clinical Trial
Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Saint Alphonsus Medical Center-Nampa
mi
from
Nampa, ID
Click here to add this to my saved trials
Oncology Clinical Trial
Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Kaiser Permanente Downtown Commons
mi
from
Sacramento, CA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Evaluate the Safety and Efficacy of MK-3102 Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus for Whom Metformin is Inappropriate (MK-3102-027)
Status: Enrolling, Phase III
Updated: 2/28/2014
Clinical Research Facility
mi
from
Columbus, GA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Evaluate the Safety and Efficacy of MK-3102 Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus for Whom Metformin is Inappropriate (MK-3102-027)
Status: Enrolling, Phase III
Updated: 2/28/2014
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Evaluate the Safety and Efficacy of MK-3102 Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus for Whom Metformin is Inappropriate (MK-3102-027)
Status: Enrolling, Phase III
Updated: 2/28/2014
Clinical Research Facility
mi
from
Los Gatos, CA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Evaluate the Safety and Efficacy of MK-3102 Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus for Whom Metformin is Inappropriate (MK-3102-027)
Status: Enrolling, Phase III
Updated: 2/28/2014
Clinical Research Facility
mi
from
Morehead City, NC
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Evaluate the Safety and Efficacy of MK-3102 Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus for Whom Metformin is Inappropriate (MK-3102-027)
Status: Enrolling, Phase III
Updated: 2/28/2014
Clinical Research Facility
mi
from
Poway, CA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Evaluate the Safety and Efficacy of MK-3102 Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus for Whom Metformin is Inappropriate (MK-3102-027)
Status: Enrolling, Phase III
Updated: 2/28/2014
Clinical Research Facility
mi
from
Toledo, OH
Click here to add this to my saved trials
Endocrinology Clinical Trial
Lysosomal Acid Lipase (LAL) Deficiency Registry
Status: Enrolling, Phase
Updated: 3/1/2018
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
Endocrinology Clinical Trial
Lysosomal Acid Lipase (LAL) Deficiency Registry
Status: Enrolling, Phase
Updated: 3/1/2018
mi
from
Bron,
Click here to add this to my saved trials
Endocrinology Clinical Trial
Lysosomal Acid Lipase (LAL) Deficiency Registry
Status: Enrolling, Phase
Updated: 3/1/2018
Clinical Research Facility
mi
from
Fairfax, VA
Click here to add this to my saved trials
Endocrinology Clinical Trial
Lysosomal Acid Lipase (LAL) Deficiency Registry
Status: Enrolling, Phase
Updated: 3/1/2018
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Urinary Bladder, Neurogenic Clinical Trial
A Study To Find Out How Fesoterodine Works In Children Aged 6 To 17 Years With Bladder Overactivity Caused By A Neurological Condition
Status: Enrolling, Phase III
Updated: 12/31/1969
Investigational Drug Services, Department of Pharmacy
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Oncology Clinical Trial
Radiation Therapy, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Locally Advanced Squamous Cell Cancer of the Vulva
Status: Enrolling, Phase II
Updated: 12/31/1969
Sanford Joe Lueken Cancer Center
mi
from
Bemidji, MN
Click here to add this to my saved trials
Oncology Clinical Trial
Radiation Therapy, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Locally Advanced Squamous Cell Cancer of the Vulva
Status: Enrolling, Phase II
Updated: 12/31/1969
SIH Cancer Institute
mi
from
Carterville, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Radiation Therapy, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Locally Advanced Squamous Cell Cancer of the Vulva
Status: Enrolling, Phase II
Updated: 12/31/1969
Capital Region Southwest Campus
mi
from
Jefferson City, MO
Click here to add this to my saved trials
Oncology Clinical Trial
Radiation Therapy, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Locally Advanced Squamous Cell Cancer of the Vulva
Status: Enrolling, Phase II
Updated: 12/31/1969
UH Seidman Cancer Center at Lake Health Mentor Campus
mi
from
Mentor, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Radiation Therapy, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Locally Advanced Squamous Cell Cancer of the Vulva
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Charles Health System-Redmond
mi
from
Redmond, OR
Click here to add this to my saved trials